Maya Pavlova

Ms. Maya Pavlova

University of Waterloo
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2022 in Frontiers in Medicine
Verified
Journal Article
Open access
MPMaya Pavlova
Maya Pavlova
NTNaomi Terhljan
Naomi Terhljan
ACAudrey G. Chung
Audrey G. Chung
AZAndy Zhao
Andy Zhao
SSSiddharth Surana
Siddharth Surana
AWAlexander Wong
Alexander Wong
As the COVID-19 pandemic devastates globally, the use of chest X-ray (CXR) imaging as a complimentary screening strategy to RT-PCR testing continues to grow given its routine clinical use for respiratory complaint. As part of the COVID-Net open source initiative, we introduce COVID-Net CXR-2, an enhanced deep convolutional neural network design for COVID-19 detection from CXR images built using a greater quantity and diversity of patients than the original COVID-Net. We also introduce a new benchmark dataset composed of 19,203 CXR images from a multinational cohort of 16,656 patients from at least 51 countries, making it the largest, most diverse COVID-19 CXR dataset in open access form. The COVID-Net CXR-2 network achieves sensitivity and positive predictive value of 95.5 and 97.0%, respectively, and was audited in a transparent and responsible manner. Explainability-driven performance validation was used during auditing to gain deeper insights in its decision-making behavior and to ensure clinically relevant factors are leveraged for improving trust in its usage. Radiologist validation was also conducted, where select cases were reviewed and reported on by two board-certified radiologists with over 10 and 19 years of experience, respectively, and showed that the critical factors leveraged by COVID-Net CXR-2 are consistent with radiologist interpretations.

9 August 2022 in BMC Medical Imaging
Verified
Journal Article
Open access
PDF file
JLJames Ren Hou Lee
James Ren Hou Lee
MPMaya Pavlova
Maya Pavlova
MFMahmoud Famouri
Mahmoud Famouri
Alexander WongAlexander Wong
Alexander Wong
Background: Skin cancer continues to be the most frequently diagnosed form of cancer in the U.S., with not only significant effects on health and well-being but also significant economic costs associated with treatment. A crucial step to the treatment and management of skin cancer is effective early detection with key screening approaches such as dermoscopy examinations, leading to stronger recovery prognoses. Motivated by the advances of deep learning and inspired by the open source initiatives in the research community, in this study we introduce Cancer-Net SCa, a suite of deep neural network designs tailored for the detection of skin cancer from dermoscopy images that is open source and available to the general public. To the best of the authors’ knowledge, Cancer-Net SCa comprises the first machine-driven design of deep neural network architectures tailored specifically for skin cancer detection, one of which leverages attention condensers for an efficient self-attention design.Results: We investigate and audit the behaviour of Cancer-Net SCa in a responsible and transparent manner through explainability-driven performance validation. All the proposed designs achieved improved accuracy when compared to the ResNet-50 architecture while also achieving significantly reduced architectural and computational complexity. In addition, when evaluating the decision making process of the networks, it can be seen that diagnostically relevant critical factors are leveraged rather than irrelevant visual indicators and imaging artifacts.Conclusion: The proposed Cancer-Net SCa designs achieve strong skin cancer detection performance on the International Skin Imaging Collaboration (ISIC) dataset, while providing a strong balance between computation and architectural efficiency and accuracy. While Cancer-Net SCa is not a production-ready screening solution, the hope is that the release of Cancer-Net SCa in open source, open access form will encourage researchers, clinicians, and citizen data scientists alike to leverage and build upon them.

23 December 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
HAHossein Aboutalebi
Hossein Aboutalebi
MPMaya Pavlova
Maya Pavlova
MSMohammad Javad Shafiee
Mohammad Javad Shafiee
ASAli Sabri
Ali Sabri
AAAmer Alaref
Amer Alaref
Alexander WongAlexander Wong
Alexander Wong
The world is still struggling in controlling and containing the spread of the COVID-19 pandemic caused by the SARS-CoV-2 virus. The medical conditions associated with SARS-CoV-2 infections have resulted in a surge in the number of patients at clinics and hospitals, leading to a significantly increased strain on healthcare resources. As such, an important part of managing and handling patients with SARS-CoV-2 infections within the clinical workflow is severity assessment, which is often conducted with the use of chest X-ray (CXR) images. In this work, we introduce COVID-Net CXR-S, a convolutional neural network for predicting the airspace severity of a SARS-CoV-2 positive patient based on a CXR image of the patient’s chest. More specifically, we leveraged transfer learning to transfer representational knowledge gained from over 16,000 CXR images from a multinational cohort of over 15,000 SARS-CoV-2 positive and negative patient cases into a custom network architecture for severity assessment. Experimental results using the RSNA RICORD dataset showed that the proposed COVID-Net CXR-S has potential to be a powerful tool for computer-aided severity assessment of CXR images of COVID-19 positive patients. Furthermore, radiologist validation on select cases by two board-certified radiologists with over 10 and 19 years of experience, respectively, showed consistency between radiologist interpretation and critical factors leveraged by COVID-Net CXR-S for severity assessment. While not a production-ready solution, the ultimate goal for the open source release of COVID-Net CXR-S is to act as a catalyst for clinical scientists, machine learning researchers, as well as citizen scientists to develop innovative new clinical decision support solutions for helping clinicians around the world manage the continuing pandemic.

9 October 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HAHossein Aboutalebi
Hossein Aboutalebi
MPMaya Pavlova
Maya Pavlova
MSMohammad Javad Shafiee
Mohammad Javad Shafiee
AFAdrian Florea
Adrian Florea
AHAndrew Hryniowski
Andrew Hryniowski
AWAlexander Wong
Alexander Wong
Since the World Health Organization declared COVID-19 a pandemic in 2020, the global community has faced ongoing challenges in controlling and mitigating the transmission of the SARS-CoV-2 virus, as well as its evolving subvariants and recombinants. A significant challenge during the pandemic has not only been the accurate detection of positive cases but also the efficient prediction of risks associated with complications and patient survival probabilities. These tasks entail considerable clinical resource allocation and attention. In this study, we introduce COVID-Net Biochem, a versatile and explainable framework for constructing machine learning models. We apply this framework to predict COVID-19 patient survival and the likelihood of developing Acute Kidney Injury during hospitalization, utilizing clinical and biochemical data in a transparent, systematic approach. The proposed approach advances machine learning model design by seamlessly integrating domain expertise with explainability tools, enabling model decisions to be based on key biomarkers. This fosters a more transparent and interpretable decision-making process made by machines specifically for medical applications. More specifically, the framework comprises two phases: In the first phase, referred to as the “clinician-guided design” phase, the dataset is preprocessed using explainable AI and domain expert input. To better demonstrate this phase, we prepared a benchmark dataset of carefully curated clinical and biochemical markers based on clinician assessments for survival and kidney injury prediction in COVID-19 patients. This dataset was selected from a patient cohort of 1366 individuals at Stony Brook University. Moreover, we designed and trained a diverse collection of machine learning models, encompassing gradient-based boosting tree architectures and deep transformer architectures, specifically for survival and kidney injury prediction based on the selected markers. In the second phase, called the “explainability-driven design refinement” phase, the proposed framework employs explainability methods to not only gain a deeper understanding of each model’s decision-making process but also to identify the overall impact of individual clinical and biochemical markers for bias identification. In this context, we used the models constructed in the previous phase for the prediction task and analyzed the explainability outcomes alongside a clinician with over 8 years of experience to gain a deeper understanding of the clinical validity of the decisions made. The explainability-driven insights obtained, in conjunction with the associated clinical feedback, are then utilized to guide and refine the training policies and architectural design iteratively. This process aims to enhance not only the prediction performance but also the clinical validity and trustworthiness of the final machine learning models. Employing the proposed explainability-driven framework, we attained 93.55% accuracy in survival prediction and 88.05% accuracy in predicting kidney injury complications. The models have been made available through an open-source platform. Although not a production-ready solution, this study aims to serve as a catalyst for clinical scientists, machine learning researchers, and citizen scientists to develop innovative and trustworthy clinical decision support solutions, ultimately assisting clinicians worldwide in managing pandemic outcomes.

1 January 2022
Verified
Conference Paper
Open access
PDF file
JBJoanna Bitton
Joanna Bitton
MPMaya Pavlova
Maya Pavlova
IEIvan Evtimov
Ivan Evtimov
Joanna Bitton, Maya Pavlova, Ivan Evtimov. Proceedings of the 2022 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies: Industry Track. 2022.

18 November 2022 in arXiv
Verified
Preprint
Open access
PDF file
MPMaya Pavlova
Maya Pavlova
TTTia Tuinstra
Tia Tuinstra
HAHossein Aboutalebi
Hossein Aboutalebi
AZAndy Zhao
Andy Zhao
HGHayden Gunraj
Hayden Gunraj
Alexander WongAlexander Wong
Alexander Wong
After more than two years since the beginning of the COVID-19 pandemic, the pressure of this crisis continues to devastate globally. The use of chest X-ray (CXR) imaging as a complementary screening strategy to RT-PCR testing is not only prevailing but has greatly increased due to its routine clinical use for respiratory complaints. Thus far, many visual perception models have been proposed for COVID-19 screening based on CXR imaging. Nevertheless, the accuracy and the generalization capacity of these models are very much dependent on the diversity and the size of the dataset they were trained on. Motivated by this, we introduce COVIDx CXR-3, a large-scale benchmark dataset of CXR images for supporting COVID-19 computer vision research. COVIDx CXR-3 is composed of 30,386 CXR images from a multinational cohort of 17,026 patients from at least 51 countries, making it, to the best of our knowledge, the most extensive, most diverse COVID-19 CXR dataset in open access form. Here, we provide comprehensive details on the various aspects of the proposed dataset including patient demographics, imaging views, and infection types. The hope is that COVIDx CXR-3 can assist scientists in advancing machine learning research against both the COVID-19 pandemic and related diseases.